Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2019 | 2016
Number of items: 2.

2019

Salwender, Hans, Bertsch, Uta, Weisel, Katja, Duerig, Jan, Kunz, Christina, Benner, Axel, Blau, Igor W., Raab, Marc Steffen, Hillengass, Jens, Hose, Dirk, Huhn, Stefanie, Hundemer, Michael, Andrulis, Mindaugas, Jauch, Anna, Seidel-Glaetzer, Andrea, Lindemann, Hans-Walter, Hensel, Manfred, Fronhoffs, Stefan, Martens, Uwe, Hansen, Timon, Wattad, Mohammed, Graeven, Ullrich, Munder, Markus, Fenk, Roland, Haenel, Mathias, Scheid, Christof and Goldschmidt, Hartmut (2019). Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma. BMC Cancer, 19. LONDON: BMC. ISSN 1471-2407

2016

Wuchter, Patrick, Bertsch, Uta, Salwender, Hans-Juergen, Munder, Markus, Haenel, Mathias, Benner, Axel, Becker, Natalia, Fenk, Roland, Duerig, Jan, Blau, Igor Wolfgang, Lisenko, Katharina, Hillengass, Jens, Raab, Marc S., Baertsch, Marc Andrea, Seidel-Glaetzer, Andrea, Ho, Anthony D., Graeven, Ullrich, Scheid, Christof, Weisel, Katja and Goldschmidt, Hartmut (2016). Evaluation of Stem Cell Mobilization in Patients with Multiple Myeloma after Lenalidomide-Based Induction Chemotherapy within the GMMG-HD6 Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Wed Jul 6 07:47:47 2022 CEST.